We are live on ! Find out more
BLTE

Belite Bio
BLTE

34 hedge funds and large institutions have $169M invested in Belite Bio in 2025 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,656% more capital invested

Capital invested by funds: $4.51M → $169M (+$165M)

140% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 5

89% more funds holding

Funds holding: 18 → 34 (+16)

6.94% more ownership

Funds ownership: 0.25% → 7.19% (+6.9%)

Holders
34
Holders Change
+16
Holders Change %
+88.89%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
12
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$57.4M
2
RI
RTW Investments
New York
+$20.5M
3
VPC
Vestal Point Capital
New York
+$20.5M
4
SCM
Soleus Capital Management
Connecticut
+$13.8M
5
EAM
Eventide Asset Management
Massachusetts
+$12.8M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$455K
2
Renaissance Technologies
Renaissance Technologies
New York
-$97.7K
3
EWA
EverSource Wealth Advisors
Alabama
-$55.4K
4
CIAM
Caitong International Asset Management
Hong Kong
-$8.21K
5
Osaic Holdings
Osaic Holdings
Arizona
-$197
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$64.8M +$57.4M +875,000 New
RI
2
RTW Investments
New York
$23.1M +$20.5M +312,500 New
VPC
3
Vestal Point Capital
New York
$23.1M +$20.5M +312,500 New
SCM
4
Soleus Capital Management
Connecticut
$15.5M +$13.8M +210,000 New
EAM
5
Eventide Asset Management
Massachusetts
$14.5M +$12.8M +195,312 New
Marshall Wace
6
Marshall Wace
United Kingdom
$13.9M +$11.7M +178,014 +1,877%
PA
7
Perceptive Advisors
New York
$3.68M +$3.27M +49,788 New
Millennium Management
8
Millennium Management
New York
$1.53M +$1.36M +20,741 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$1.16M +$181K +2,761 +21%
State Street
10
State Street
Massachusetts
$982K -$455K -6,930 -34%
BNP Paribas Financial Markets
11
BNP Paribas Financial Markets
France
$855K +$542K +8,258 +251%
UBS Group
12
UBS Group
Switzerland
$839K +$589K +8,976 +381%
Citadel Advisors
13
Citadel Advisors
Florida
$801K +$221K +3,371 +45%
JP Morgan Chase
14
JP Morgan Chase
New York
$726K +$200K +3,052 +45%
PCMH
15
Polymer Capital Management (HK)
Hong Kong
$538K +$477K +7,266 New
Morgan Stanley
16
Morgan Stanley
New York
$387K +$310K +4,723 +932%
CUAMC
17
China Universal Asset Management Company
China
$370K +$328K +5,000 New
CSS
18
Cubist Systematic Strategies
Connecticut
$344K +$117K +1,776 +62%
Citigroup
19
Citigroup
New York
$297K +$263K +4,010 New
QC
20
Quadrature Capital
United Kingdom
$283K +$251K +3,830 New
Goldman Sachs
21
Goldman Sachs
New York
$274K +$243K +3,706 New
HNWAG
22
High Net Worth Advisory Group
Florida
$259K +$230K +3,500 New
Point72 Asset Management
23
Point72 Asset Management
Connecticut
$229K +$118K +1,800 +138%
Ameriprise
24
Ameriprise
Minnesota
$224K +$199K +3,031 New
Renaissance Technologies
25
Renaissance Technologies
New York
$208K -$97.7K -1,488 -35%
1
2

BLTE Hedge Fund Activity: Q3 2025 in Review

34 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Belite Bio (BLTE) for Q3 2025, worth a combined $169M — up 3,656% from $4.51M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BLTE positions and 0 closed out — a net gain of 16 holders — while 12 added to existing stakes and 5 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $57.4M. The largest seller was State Street, cutting an estimated $455K.

  • 34 institutional investors held Belite Bio (BLTE) as of Q3 2025, up from 18 in Q2 2025.
  • Funds reported $169M of Belite Bio stock for Q3 2025, up 3,656% quarter-over-quarter.
  • 16 funds opened new Belite Bio positions in Q3 2025 and 0 closed out, a net change of +16 holders.
  • The largest Belite Bio buyer in Q3 2025 was RA Capital Management, an estimated $57.4M added.
  • The largest Belite Bio seller in Q3 2025 was State Street, an estimated $455K sold.

Based on aggregated 13F filings for Q3 2025.